Concord Drugs Ltd Annually Results

Gross Sales

44.92

52.08

58.96

Excise Duty

0

0

0

Net Sales

44.92

52.08

58.96

Other Operating Income

0.01

0.01

0.1

Other Income

0

0

0

Total Income

44.93

52.09

59.06

Total Expenditure

40.88

47.51

53.36

PBIDT

4.05

4.58

5.69

Interest

1.87

1.71

1.68

PBDT

2.18

2.87

4.01

Depreciation

1.56

1.63

1.76

Minority Interest Before NP

0

0

0

Tax

0.22

0.38

0.67

Deferred Tax

-0.06

-0.12

-0.02

Reported Profit After Tax

0.47

0.99

1.59

Minority Interest After NP

0

0

0

Net Profit after Minority Interest

0.47

0.99

1.59

Extra-ordinary Items

0

0

0

Adjusted Profit After Extra-ordinary item

0.47

0.99

1.59

EPS (Unit Curr.)

0.47

1.06

1.82

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

10

9.32

8.74

Public Shareholding (Number)

0

0

0

Public Shareholding (%)

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

9.01

8.79

9.65

PBDTM(%)

4.85

5.51

6.8

PATM(%)

1.04

1.9

2.69